Business Context and Reporting Period
This Form 6-K filing by TNL Mediagene, dated November 25, 2024, reports on recent financing transactions executed in connection with a pending Merger. The filing details the closing of a private placement of convertible notes and the signing of new agreements for additional convertible notes and an equity line of credit.
Key Financial Metrics and Capital Structure
- Convertible Notes Closed (Nov 22, 2024): Raised $4,355,000 in aggregate principal. Notes bear 10.0% annual interest and mature on December 7, 2024, unless converted into ordinary shares prior to the Merger closing.
- New Convertible Notes Agreement (Nov 25, 2024): Agreed to issue up to $11,944,444 in senior unsecured convertible notes (including a 10% original issue discount). The initial tranche is expected to be $4,722,222 ($4,250,000 net of discount). These notes accrue 6% simple interest and mature 12 months after issuance.
- Equity Line of Credit (ELOC): Signed an agreement allowing the issuance of up to $30,000,000 of ordinary shares. Purchases are subject to daily volume limits and priced at 97% of the lowest daily VWAP.
- Warrant Assignments: The Sponsor (Blue Ocean Sponsor LLC) assigned private placement warrants to investors in the initial convertible note transaction. These warrants allow the acquisition of Class A ordinary shares at an exercise price of $11.50 per share.
Material Changes and Transaction Details
The filing discloses significant changes to the company's capital structure through the introduction of new debt and equity instruments:
- Debt Seniority: The new Notes issued under the Note SPA rank senior to all present and future indebtedness, subject to permitted senior indebtedness, and are guaranteed by TNL Mediagene's subsidiaries.
- Conversion Mechanics: The new Notes are convertible at a price equal to 125% of the lower of the Nasdaq closing price on the 5th trading day post-Merger or the 5-day average closing price post-Merger. The company retains a right to redeem portions of the notes monthly via conversion at a discounted price (92% of lowest VWAP).
- Dilution Limits: Conversion of the new Notes is restricted if it would cause a Note Buyer to own more than 4.99% of the outstanding ordinary shares.
Outlook, Risks, and Management Commentary
Management has secured financing to support the Merger and future operations. Key terms and risks include:
- Registration Rights: The company must file registration statements for the resale of shares underlying the Convertible Notes and ELOC within 30 to 45 days post-closing, with efforts to have them declared effective within 120 days.
- Preemptive Rights: Note Buyers have the right to participate in up to 25% of future financings on the same terms.
- Restrictions: The company faces restrictions on issuing additional equity securities or engaging in dilutive issuances while the Notes are outstanding.
- Termination: The right to issue Additional Notes under the Note SPA terminates 12 months after the Merger if no subsequent closing has occurred.
Investor Verification Checklist
- Verify the exact closing date of the Merger to determine the conversion price for the new Notes and the maturity date of the initial Convertible Notes.
- Confirm the total amount of cash actually received from the initial tranche of the Note SPA after deducting fees and the 10% original issue discount.
- Review the specific terms of the "permitted senior indebtedness" to understand the hierarchy of the new debt relative to existing obligations.
- Monitor the filing of the required registration statements (Form S-1 or F-3) to ensure liquidity for the investors and compliance with the 30-45 day filing deadline.
- Assess the impact of the 4.99% beneficial ownership limitation on the company's ability to raise further capital through these instruments.